Quoin Pharmaceuticals, Ltd. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/676fd185-b126-484e-adab-bba3addc65ce/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-15.8M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-080828 |
| FY 2024 | $-9.0M | 2024-01-01 – 2024-12-31 | evidence 0001104659-26-080828 |
| FY 2023 | $-8.7M | 2023-01-01 – 2023-12-31 | evidence 0001104659-26-080828 |
| FY 2022 | $-9.4M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000267 |
| FY 2021 | $-21.5M | 2021-01-01 – 2021-12-31 | evidence 0001104659-22-045620 |
| FY 2020 | $-2.1M | 2020-01-01 – 2020-12-31 | evidence 0001104659-22-045620 |
| FY 2019 | $-1.6M | 2019-01-01 – 2019-12-31 | evidence 0001104659-22-045620 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).